11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
Man-of-the-people PM Boris Johnson is set to as the Queen to suspend parliament for 5 weeks in an at...
Read More >
The COVID-19 coronavirus is impacting every aspect of the economy, and construction will not be exem...
Read More >
On August 9, 2019, Illinois Governor J.B. Pritzker signed into law a sweeping piece of legislation, ...
Read More >
Increasingly, utilities are replacing older generation fleets with more cost-effective generation te...
Read More >
As the UK departs the European Union, the CMA – the UK competition regulator – is facing a transfo...
Read More >
In William Lansing v. Doe, 2019 Ore. App. LEXIS 1564, the Court of Appeals of Oregon considered whet...
Read More >